Immutep Limited
PRRUF
$0.04
-$0.01-21.11%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 59.81% | 45.50% | 30.09% | 26.85% | 23.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.99% | 45.71% | 30.32% | 26.96% | 23.42% |
| Cost of Revenue | 74.38% | 59.69% | 45.38% | 34.33% | 22.40% |
| Gross Profit | -76.07% | -61.23% | -46.91% | -35.13% | -22.28% |
| SG&A Expenses | 16.29% | 5.35% | -3.61% | -7.88% | -12.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.59% | 50.84% | 36.78% | 26.44% | 15.56% |
| Operating Income | -66.14% | -51.31% | -37.31% | -26.40% | -14.85% |
| Income Before Tax | -87.17% | -63.61% | -41.17% | -24.65% | -7.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -87.17% | -63.61% | -41.17% | -24.65% | -7.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -87.17% | -63.61% | -41.17% | -24.65% | -7.60% |
| EBIT | -66.14% | -51.31% | -37.31% | -26.40% | -14.85% |
| EBITDA | -63.06% | -50.40% | -38.52% | -28.30% | -17.63% |
| EPS Basic | -69.72% | -41.59% | -16.74% | 0.81% | 16.15% |
| Normalized Basic EPS | -71.11% | -42.14% | -16.55% | 1.31% | 16.67% |
| EPS Diluted | -69.72% | -41.59% | -16.74% | 0.81% | 16.15% |
| Normalized Diluted EPS | -71.11% | -42.14% | -16.55% | 1.31% | 16.67% |
| Average Basic Shares Outstanding | 9.74% | 15.18% | 21.21% | 24.05% | 27.30% |
| Average Diluted Shares Outstanding | 9.74% | 15.18% | 21.21% | 24.05% | 27.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |